Brief: Lipocine Inc Announces Positive Oral Brexanolone QEEG Results
10/10/2024 11:26
Oct 10 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE INC: ANNOUNCES POSITIVE ORAL BREXANOLONE QEEG
RESULTS
* LIPOCINE INC: PHASE 1 STUDY EVALUATED QEEG CHANGES IN
HEALTHY
POSTMENOPAUSAL FEMALES
* LIPOCINE INC: ORAL BREXANOLONE WELL-TOLERATED WITH MINIMAL
CNS
DEPRESSANT EFFECTS
Source text for Eikon: ID:n0001493152-24-040651
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy